We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UEC icon
3426
Uranium Energy
UEC
$5.55B
$5.83M ﹤0.01%
1,894,100
+1,367,735
+260% +$5.69M
AEG icon
3427
Aegon
AEG
$14B
$5.83M ﹤0.01%
1,362,808
-2,650,038
-66% -$13.1M
SRE icon
3428
PUT
Sempra
SRE
$56.5B
$5.83M ﹤0.01%
77,600
-69,200
-47% -$5.56M
CYH icon
3429
Community Health Systems
CYH
$423M
$5.82M ﹤0.01%
1,552,848
+982,235
+172% +$6.92M
SDS icon
3430
PUT
ProShares UltraShort S&P500
SDS
$366M
$5.82M ﹤0.01%
23,136
+6,032
+35% +$1.35M
STN icon
3431
Stantec
STN
$8.28B
$5.81M ﹤0.01%
132,775
+78,991
+147% +$3.62M
HAL icon
3432
Halliburton
HAL
$28.7B
$5.81M ﹤0.01%
185,369
-537,128
-74% -$20M
FRC
3433
CALL
DELISTED
First Republic Bank
FRC
$5.81M ﹤0.01%
40,300
-55,100
-58% -$8.26M
BOND icon
3434
PIMCO Active Bond Exchange-Traded Fund
BOND
$8.47B
$5.81M ﹤0.01%
60,952
+30,913
+103% +$3M
KLIC icon
3435
CALL
Kulicke & Soffa
KLIC
$5.19B
$5.8M ﹤0.01%
135,400
-21,200
-14% -$1.05M
RL icon
3436
Ralph Lauren
RL
$23.2B
$5.79M ﹤0.01%
64,584
-2,349
-4% -$237K
OMF icon
3437
CALL
OneMain Financial
OMF
$7.56B
$5.79M ﹤0.01%
154,800
+36,000
+30% +$1.56M
JXN icon
3438
Jackson Financial
JXN
$9.17B
$5.78M ﹤0.01%
216,223
+129,427
+149% +$4.72M
CALM icon
3439
CALL
Cal-Maine
CALM
$3.8B
$5.78M ﹤0.01%
117,000
-18,700
-14% -$949K
XRT icon
3440
State Street SPDR S&P Retail ETF
XRT
$640M
$5.78M ﹤0.01%
99,337
+65,333
+192% +$4.45M
ALGM icon
3441
PUT
Allegro MicroSystems
ALGM
$8.27B
$5.78M ﹤0.01%
279,100
-691,000
-71% -$16.5M
DVY icon
3442
PUT
iShares Select Dividend ETF
DVY
$24.1B
$5.77M ﹤0.01%
49,000
+20,300
+71% +$2.54M
NU icon
3443
CALL
Nu Holdings
NU
$73.6B
$5.76M ﹤0.01%
1,539,700
+515,600
+50% +$2.62M
TGH
3444
CALL
DELISTED
Textainer Group Holdings limited
TGH
$5.76M ﹤0.01%
210,000
+54,100
+35% +$1.75M
BXP icon
3445
PUT
Boston Properties
BXP
$10.9B
$5.75M ﹤0.01%
64,600
+16,500
+34% +$1.83M
BCRX icon
3446
BioCryst Pharmaceuticals
BCRX
$2.49B
$5.74M ﹤0.01%
542,461
+93,305
+21% +$962K
TXRH icon
3447
PUT
Texas Roadhouse
TXRH
$13.6B
$5.74M ﹤0.01%
78,400
+20,100
+34% +$1.58M
JSPR icon
3448
Jasper Therapeutics
JSPR
$26.3M
$5.74M ﹤0.01%
297,300
-2,158
-0.7% -$61.5K
BE icon
3449
Bloom Energy
BE
$67.7B
$5.74M ﹤0.01%
347,631
-685,125
-66% -$12.5M
SG icon
3450
Sweetgreen
SG
$748M
$5.74M ﹤0.01%
+492,383
New +$10.4M

Similar funds

Citadel Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.